Literature DB >> 10424769

9-[2-(Phosphonomethoxy)ethyl]adenine diphosphate (PMEApp) as a substrate toward replicative DNA polymerases alpha, delta, epsilon, and epsilon*.

G Birkus1, I Votruba, A Holý, B Otová.   

Abstract

The diphosphoryl derivative of the acyclic nucleotide phosphonate analog 9-[2-(phosphonomethoxy)ethyl]adenine (PMEA), found previously to weakly inhibit DNA pol delta/proliferating cell nuclear antigen, was studied as a substrate for pol alpha, delta, epsilon, and epsilon*. A comparison of the Vmax and Km for this derivative (PMEApp) and dATP demonstrated that the relative efficiency of the incorporation of this analog into the DNA chain is decreasing in the following order: pol delta approximately equal to pol epsilon approximately equal to pol epsilon* > pol alpha. Under the reaction conditions, this incorporation amounted to 4.4 to 0.7% of dAMP molecules. Similar Km values for PMEApp and dATP in pol epsilon and pol epsilon* catalyzed reactions revealed that proteolysis of the enzyme probably does not affect the dNTP binding site. The DNA polymerases tested were inhibited by the reaction product (PMEA terminated DNA chain) with similar Ki/Km ratios (pol alpha 0.2; pol delta, 0.1; pol epsilon 0.05; and pol epsilon*, 0.06). The associated 3'-5'-exonuclease activity of pol delta, epsilon, and epsilon* was able to excise PMEA from the 3'-OH end of DNA with a rate one order of magnitude lower than that of the dAMP residue.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10424769     DOI: 10.1016/s0006-2952(99)00118-5

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  5 in total

1.  Tenofovir diphosphate is a poor substrate and a weak inhibitor of rat DNA polymerases alpha, delta, and epsilon*.

Authors:  Gabriel Birkus; Miroslav Hájek; Pavel Kramata; Ivan Votruba; Antonín Holý; Berta Otová
Journal:  Antimicrob Agents Chemother       Date:  2002-05       Impact factor: 5.191

2.  Quantification of isomeric equilibria formed by metal ion complexes of 8-[2-(phosphonomethoxy)ethyl]-8-azaadenine (8,8aPMEA) and 9-[2-(phosphonomethoxy)ethyl]-8-azaadenine (9,8aPMEA). Derivatives of the antiviral nucleotide analogue 9-[2-(phosphonomethoxy)ethyl]adenine (PMEA).

Authors:  Raquel B Gómez-Coca; Larisa E Kapinos; Antonín Holý; Rosario A Vilaplana; Francisco González-Vílchez; Helmut Sigel
Journal:  J Biol Inorg Chem       Date:  2004-10-20       Impact factor: 3.358

Review 3.  Clinical potential of the acyclic nucleoside phosphonates cidofovir, adefovir, and tenofovir in treatment of DNA virus and retrovirus infections.

Authors:  Erik De Clercq
Journal:  Clin Microbiol Rev       Date:  2003-10       Impact factor: 26.132

Review 4.  Comparison of the π-stacking properties of purine versus pyrimidine residues. Some generalizations regarding selectivity.

Authors:  Astrid Sigel; Bert P Operschall; Helmut Sigel
Journal:  J Biol Inorg Chem       Date:  2014-01-25       Impact factor: 3.358

5.  Synthesis and substrate properties towards HIV-1 reverse transcriptase of new diphosphate analogues of 9-[(2-phosphonomethoxy)ethyl]adenine.

Authors:  Wolfgang Hg Laux; Stéphane Priet; Karine Alvarez; Suzanne Peyrottes; Christian Périgaud
Journal:  Antivir Chem Chemother       Date:  2018 Jan-Dec
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.